Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about S100A8: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
S100A8 is a gene implicated in neurodegeneration research. Key relationships include: regulates, associated with, inhibits. Associated with ALS, Als, Atherosclerosis. Connected to 151 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | S100A8 |
| Full Name | S100 Calcium Binding Protein A8 |
| Chromosome | 1q21.3 |
| Protein Family | S100 calcium-binding protein family |
| Function | S100A8 and the S100A8/A9 complex (calprotectin) have several critical functions |
| Primary Expression | specific cell types and pathological conditions |
| Molecular Weight | 10.8 kDa |
| Amino Acids | 93 aa |
| Exons | 3 |
| Pathways | NF-κB, MAPK signaling |
| GeneCards | S100A8 |
| Human Protein Atlas | S100A8 |
| N-terminal hinge region | Low complexity region involved in protein interactions |
| EF-hand I (pseudo) | Non-functional calcium-binding site at N-terminus |
| EF-hand II (canonical) | Functional calcium-binding site at C-terminus |
| Associated Diseases | Alzheimer, Cancer, Heart Failure, Lupus, Ms, Sepsis |
| Known Drugs/Compounds | GW201 |
| Interactions | ACE2, Actin, AGING, AMPK, AND, APOPTOSIS |
| KG Connections | 299 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
S100A8["S100A8"]
S100A8 -->|"inhibits"| Ms["Ms"]
S100A8 -->|"regulates"| Als["Als"]
S100A8 -->|"interacts"| Inflammation["Inflammation"]
S100A8 -->|"activates"| Cancer["Cancer"]
S100A8 -->|"inhibits"| Spinal_Cord_Injury["Spinal Cord Injury"]
S100A8 -->|"regulates"| ALS["ALS"]
S100A8 -->|"interacts"| TLR4["TLR4"]
CSF2["CSF2"] -->|"regulates"| S100A8
NAMPT["NAMPT"] -->|"regulates"| S100A8
FGF2["FGF2"] -->|"regulates"| S100A8
CXCL10["CXCL10"] -->|"regulates"| S100A8
HSPA1A["HSPA1A"] -->|"regulates"| S100A8
FGF8["FGF8"] -->|"regulates"| S100A8
TLR4 -->|"regulates"| S100A8
ISG15["ISG15"] -->|"regulates"| S100A8
STAT1["STAT1"] -->|"regulates"| S100A8
CSF2RA["CSF2RA"] -->|"regulates"| S100A8| Target | Relation | Type | Str |
|---|---|---|---|
| Th17/Th22 Pathway | involved_in | pathway | 0.85 |
| AGING | upregulates | process | 0.80 |
| Tumor | associated_with | disease | 0.75 |
| inflammatory response | promotes | process | 0.75 |
| ALS | expressed_in | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| ALS | regulates | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Heart Failure | causes | disease | 0.65 |
| Myocardial Infarction | biomarker_for | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Fibrosis | activates | disease | 0.65 |
| Inflammation | inhibits | disease | 0.65 |
| Sepsis | associated_with | disease | 0.65 |
| Inflammation | interacts_with | disease | 0.65 |
| Neuroinflammation | inhibits | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Traumatic Brain Injury | inhibits | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Multiple Sclerosis | interacts_with | disease | 0.65 |
| Fibrosis | inhibits | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Obesity | inhibits | disease | 0.65 |
| Stroke | associated_with | disease | 0.65 |
| Als | interacts_with | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Infection | interacts_with | disease | 0.65 |
| Atherosclerosis | expressed_in | disease | 0.65 |
| Inflammation | expressed_in | disease | 0.65 |
| Neuroinflammation | therapeutic_target | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Lupus | associated_with | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Spinal Cord Injury | inhibits | disease | 0.65 |
| Als | biomarker_for | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| TLR4 | interacts_with | protein | 0.64 |
| HO-1 | inhibits | gene | 0.60 |
| BRAIN INJURY | inhibits | gene | 0.60 |
| NEUROINFLAMMATION | inhibits | gene | 0.60 |
| INFLAMMATION | expressed_in | gene | 0.60 |
| Toll-Like Receptor | associated_with | pathway | 0.60 |
| Phagocytosis | associated_with | pathway | 0.60 |
| Apoptosis | associated_with | pathway | 0.60 |
| Autophagy | associated_with | pathway | 0.60 |
| Oxidative Stress | activates | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| GW201 | modulates | compound | 0.85 |
| GW201 | downregulates | compound | 0.75 |
| MMP9 | associated_with | gene | 0.60 |
| BAX | activates | gene | 0.60 |
| P38 | regulates | gene | 0.60 |
| PI3K | regulates | gene | 0.60 |
| TLR4 | inhibits | gene | 0.60 |
| MMP2/MMP9 | inhibits | gene | 0.60 |
| IFNG | expressed_in | gene | 0.60 |
| BECN1 | associated_with | gene | 0.60 |
| ATG5 | associated_with | gene | 0.60 |
| FIP200 | associated_with | gene | 0.60 |
| RB1 | associated_with | gene | 0.60 |
| IFNG | associated_with | gene | 0.60 |
| LC3 | associated_with | gene | 0.60 |
| ATG14 | associated_with | gene | 0.60 |
| MAP1LC3A | associated_with | gene | 0.60 |
| CASP1 | associated_with | gene | 0.60 |
| TNF | associated_with | gene | 0.60 |
| TLR4 | associated_with | gene | 0.60 |
| S100A9 | inhibits | gene | 0.60 |
| NLRP3 | inhibits | gene | 0.60 |
| IL18 | inhibits | gene | 0.60 |
| NLRP1 | inhibits | gene | 0.60 |
| IL1B | inhibits | gene | 0.60 |
| S100A9 | regulates | gene | 0.60 |
| AND | therapeutic_target | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| ROS | activates | gene | 0.60 |
| AMPK | inhibits | gene | 0.60 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.60 |
| STROKE | associated_with | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| CLDN1 | inhibits | gene | 0.60 |
| CD31 | expressed_in | gene | 0.60 |
| GENES | inhibits | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| NF-ΚB | interacts_with | gene | 0.60 |
| EPOR | regulates | gene | 0.60 |
| EPO | regulates | gene | 0.60 |
| NF-ΚB | inhibits | gene | 0.60 |
| TNF-Α | inhibits | gene | 0.60 |
| GENES | regulates | gene | 0.60 |
| GENES | expressed_in | gene | 0.60 |
| INFLAMMATION | expressed_in | gene | 0.60 |
| MTDNA | activates | gene | 0.60 |
| S100A9 | associated_with | gene | 0.60 |
| AGING | activates | gene | 0.60 |
| NAMPT | regulates | gene | 0.60 |
| FGF2 | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning S100A8 in their description or question text
No additional research found